Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure - A Multicenter, Double-blind, Placebo Controlled Prospective Trial With Two Arms

NCT01065194 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.

NCT NCT01065194
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01065194 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure - A Multicenter, Double-blind, Placebo Controlled Prospective Trial With Two Arms
Lead sponsor
Medical University Innsbruck
Phase
Phase 3
Overall status
Unknown status
Start date
August 31, 2009
Completion date
August 31, 2011
Enrollment
120 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic stable heart failure